152 related articles for article (PubMed ID: 7177273)
1. Lecithin: cholesterol acyltransferase activity in dialyzed and undialyzed chronic uremic patients.
Bories PC; Subbaiah PV; Bagdade JD
Nephron; 1982; 32(1):22-7. PubMed ID: 7177273
[TBL] [Abstract][Full Text] [Related]
2. Lecithin-cholesterol acyltransferase (LCAT) activity in chronic uremia.
Guarnieri GF; Moracchiello M; Campanacci L; Ursini F; Ferri L; Valente M; Gregolin C
Kidney Int Suppl; 1978 Jun; (8):S26-30. PubMed ID: 278893
[TBL] [Abstract][Full Text] [Related]
3. Plasma lipids and acyltransferase activities in experimental nephrotic syndrome.
Sestak TL; Alavi N; Subbaiah PV
Kidney Int; 1989 Aug; 36(2):240-8. PubMed ID: 2779094
[TBL] [Abstract][Full Text] [Related]
4. Increased lysolecithin acyltransferase activity in the plasma of type II hyperlipoproteinemic patients.
Subbaiah PV; Ogilvie JT
Lipids; 1984 Feb; 19(2):80-4. PubMed ID: 6708755
[TBL] [Abstract][Full Text] [Related]
5. Molecular species of phosphatidylcholine in abetalipoproteinemia: effect of lecithin:cholesterol acyltransferase and lysolecithin acyltransferase.
Banerji B; Subbaiah PV; Gregg RE; Bagdade JD
J Lipid Res; 1989 Dec; 30(12):1907-16. PubMed ID: 2621418
[TBL] [Abstract][Full Text] [Related]
6. Lipid and lipoprotein levels in undialyzed patients with chronic renal failure.
Mendez A; Perez GO; Goldberg RB; Hsia SL
Am J Med Sci; 1987 Mar; 293(3):164-70. PubMed ID: 3565463
[TBL] [Abstract][Full Text] [Related]
7. Plasma lipoproteins and lecithin:cholesterol acyltransferase distribution in patients on dialysis.
McLeod R; Reeve CE; Frohlich J
Kidney Int; 1984 Apr; 25(4):683-8. PubMed ID: 6482172
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of hepatic lecithin:cholesterol acyltransferase gene expression in chronic renal failure.
Vaziri ND; Liang K; Parks JS
Kidney Int; 2001 Jun; 59(6):2192-6. PubMed ID: 11380821
[TBL] [Abstract][Full Text] [Related]
9. Impairment of lecithin:cholesterol acyltransferase (LCAT) activity in hemodialyzed subjects. I. No evidence of plasma LCAT-inhibiting factors.
Sasso GF; Ceccanti M; Di Giovanni MG; Nardi E; Pilatone P; Pisculli M; Romeo M; Tersigni R; Chiarioni T
Panminerva Med; 1984; 26(2):97-100. PubMed ID: 6483462
[No Abstract] [Full Text] [Related]
10. Plasma lecithin-cholesterol acyltransferase activities in uraemic patients.
Chan MK; Ramdial L; Varghese Z; Persaud JW; Baillod RA; Moorhead JF
Clin Chim Acta; 1982 Feb; 119(1-2):65-72. PubMed ID: 7060276
[TBL] [Abstract][Full Text] [Related]
11. Effect of apoprotein B conformation on the activation of lysolecithin acyltransferase and lecithin: cholesterol acyltransferase. Studies with subfractions of low density lipoproteins.
Liu M; Krul ES; Subbaiah PV
J Biol Chem; 1992 Mar; 267(8):5139-47. PubMed ID: 1544896
[TBL] [Abstract][Full Text] [Related]
12. Relationship between plasma lecithin:cholesterol acyltransferase activity and plasma triglyceride concentration in non-pregnant and pregnant Brazilian women.
Gillett MP; Silva TB
Scand J Clin Lab Invest Suppl; 1978; 150():118-23. PubMed ID: 218270
[TBL] [Abstract][Full Text] [Related]
13. Effect of long-term hemodialysis on plasma lecithin: cholesterol acyltransferase activity and the amounts and compositions of HDL2 and HDL3 in hemodialysis-treated patients with chronic renal failure: a 9-year longitudinal study.
Mekki K; Bouchenak M; Remaoun M; Belleville JL
Med Sci Monit; 2004 Aug; 10(8):CR439-46. PubMed ID: 15277993
[TBL] [Abstract][Full Text] [Related]
14. Low density lipoprotein-activated lysolecithin acylation by human plasma lecithin-cholesterol acyltransferase. Identity of lysolecithin acyltransferase and lecithin-cholesterol acyltransferase.
Subbaiah PV; Albers JJ; Chen CH; Bagdade JD
J Biol Chem; 1980 Oct; 255(19):9275-80. PubMed ID: 7410425
[TBL] [Abstract][Full Text] [Related]
15. Lecithin: cholesterol acyltransferase (LCAT) activity in long-term hemodialyzed subjects.
Sasso GF; Ceccanti M; Nardi E; Palestini M; Pilatone F; Pisculli M; Romeo M; Tersigni R; Chiarioni T
Panminerva Med; 1984; 26(3):177-80. PubMed ID: 6522079
[No Abstract] [Full Text] [Related]
16. [Lecithin cholesterol acyltransferase (LCAT) and lipid cardiovascular risk factors in hemodialysis patients].
Sassolas A; Courboules P; Leitienne P; Quincy C; Galland R; Traeger J
Nephrologie; 1987; 8(5):267-72. PubMed ID: 3444496
[TBL] [Abstract][Full Text] [Related]
17. Requirement of low density lipoproteins for the lysolecithin acyl transferase activity in human plasma: assay of enzyme activity in abetalipoproteinemic patients.
Subbaiah PV
Metabolism; 1982 Mar; 31(3):294-8. PubMed ID: 7078415
[TBL] [Abstract][Full Text] [Related]
18. Association of lecithin-cholesterol acyltransferase activity measured as a serum cholesterol esterification rate and low-density lipoprotein heterogeneity with cardiovascular risk: a cross-sectional study.
Tani S; Takahashi A; Nagao K; Hirayama A
Heart Vessels; 2016 Jun; 31(6):831-40. PubMed ID: 25894629
[TBL] [Abstract][Full Text] [Related]
19. Lecithin: cholesterol acyltransfer, dyslipoproteinaemia and membrane lipids in uraemia.
Gillett MP; Obineche EN; El-Rokhaimi M; Lakhani MS; Abdulle A; Sulaiman M
J Nephrol; 2001; 14(6):472-80. PubMed ID: 11783603
[TBL] [Abstract][Full Text] [Related]
20. Association of lecithin-cholesterol acyltransferase activity and low-density lipoprotein heterogeneity with atherosclerotic cardiovascular disease risk: a longitudinal pilot study.
Yokoyama K; Tani S; Matsuo R; Matsumoto N
BMC Cardiovasc Disord; 2018 Dec; 18(1):224. PubMed ID: 30518338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
